Shutoku Matsuyama

InstitutionNational Institute of Infectious Diseases
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 12 Covid-19 publications, with a maximum of 2 publications in February 2021
    All Publications
    Bar chart showing 60 publications over 20 distinct years, with a maximum of 7 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shirato K, Matsuyama S, Takeda M. Less Frequent Sequence Mismatches in Variants of Concern (VOCs) of SARS-CoV-2 in the Real-Time RT-PCR Assays Developed by the National Institute of Infectious Diseases, Japan. Jpn J Infect Dis. 2022 Jan 24; 75(1):96-101. PMID: 34193667.
      Citations:    Fields:    
    2. Tomita Y, Matsuyama S, Fukuhara H, Maenaka K, Kataoka H, Hashiguchi T, Takeda M. The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection. J Virol. 2021 05 24; 95(12). PMID: 33789993.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    3. Tomita Y, Takeda M, Matsuyama S. The anti-influenza virus drug favipiravir has little effect on replication of SARS-CoV-2 in cultured cells. Antimicrob Agents Chemother. 2021 Mar 01. PMID: 33649117.
      Citations: 2     Fields:    
    4. Shirato K, Tomita Y, Katoh H, Yamada S, Fukushi S, Matsuyama S, Takeda M. Performance Evaluation of Real-Time RT-PCR Assays for the Detection of Severe Acute Respiratory Syndrome Coronavirus-2 Developed by the National Institute of Infectious Diseases, Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):465-472. PMID: 33642428.
      Citations: 1     Fields:    Translation:Humans
    5. Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K, Suzuki M, Gu Y, Sakaguchi M, Tajima T, Takaya S, Ohmagari N, Takeda M, Matsuyama S, Shirato K, Nao N, Hasegawa H, Kageyama T, Takayama I, Saito S, Wada K, Fujita R, Saito H, Okinaka K, Griffith M, Parry AE, Barnetson B, Leonard J, Wakita T. Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship. J Infect Dis. 2021 02 13; 223(3):540. PMID: 32905593.
      Citations:    Fields:    
    6. Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, Shimojima M, Fukushi S. The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. J Virol. 2020 12 09; 95(1). PMID: 33055254.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    7. Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K, Suzuki M, Gu Y, Sakaguchi M, Tajima T, Takaya S, Ohmagari N, Takeda M, Matsuyama S, Shirato K, Nao N, Hasegawa H, Kageyama T, Takayama I, Saito S, Wada K, Fujita R, Saito H, Okinaka K, Griffith M, Parry AE, Barnetson B, Leonard J, Wakita T. Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship. J Infect Dis. 2020 09 01; 222(7):1098-1102. PMID: 32691828.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    8. Kato F, Matsuyama S, Kawase M, Hishiki T, Katoh H, Takeda M. Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2. Microbiol Immunol. 2020 Sep; 64(9):635-639. PMID: 32579258.
      Citations: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Shirato K, Nao N, Matsuyama S, Takeda M, Kageyama T. An Ultra-Rapid Real-Time RT-PCR Method Using the PCR1100 to Detect Severe Acute Respiratory Syndrome Coronavirus-2. Jpn J Infect Dis. 2021 Jan 22; 74(1):29-34. PMID: 32611983.
      Citations: 2     Fields:    Translation:Humans
    10. Okamaoto K, Shirato K, Nao N, Saito S, Kageyama T, Hasegawa H, Suzuki T, Matsuyama S, Takeda M. Assessment of Real-Time RT-PCR Kits for SARS-CoV-2 Detection. Jpn J Infect Dis. 2020 Sep 24; 73(5):366-368. PMID: 32350226.
      Citations: 15     Fields:    Translation:HumansCells
    11. Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M, Tahara M, Kutsuna S, Ohmagari N, Kuroda M, Suzuki T, Kageyama T, Takeda M. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020 03 31; 117(13):7001-7003. PMID: 32165541.
      Citations: 393     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    12. Shirato K, Nao N, Katano H, Takayama I, Saito S, Kato F, Katoh H, Sakata M, Nakatsu Y, Mori Y, Kageyama T, Matsuyama S, Takeda M. Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan. Jpn J Infect Dis. 2020 07 22; 73(4):304-307. PMID: 32074516.
      Citations: 133     Fields:    Translation:HumansCellsPHPublic Health
    13. Kazuya S, Nao N, Matsuyama S, Kageyama T. Ultra-Rapid Real-Time RT-PCR Method for Detecting Middle East Respiratory Syndrome Coronavirus Using a Mobile PCR Device, PCR1100. Jpn J Infect Dis. 2020 May 22; 73(3):181-186. PMID: 31875608.
      Citations: 4     Fields:    Translation:CellsPHPublic Health
    14. Kawase M, Kataoka M, Shirato K, Matsuyama S. Biochemical Analysis of Coronavirus Spike Glycoprotein Conformational Intermediates during Membrane Fusion. J Virol. 2019 10 01; 93(19). PMID: 31315988.
      Citations: 10     Fields:    Translation:AnimalsCells
    15. Shirato K, Melaku SK, Kawachi K, Nao N, Iwata-Yoshikawa N, Kawase M, Kamitani W, Matsuyama S, Tessema TS, Sentsui H. Middle East Respiratory Syndrome Coronavirus in Dromedaries in Ethiopia Is Antigenically Different From the Middle East Isolate EMC. Front Microbiol. 2019; 10:1326. PMID: 31275264.
      Citations: 10     
    16. Matsuyama S, Shirato K, Kawase M, Terada Y, Kawachi K, Fukushi S, Kamitani W. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells. J Virol. 2018 10 01; 92(19). PMID: 30021905.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    17. Shirato K, Semba S, El-Kafrawy SA, Hassan AM, Tolah AM, Takayama I, Kageyama T, Notomi T, Kamitani W, Matsuyama S, Azhar EI. Development of fluorescent reverse transcription loop-mediated isothermal amplification (RT-LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus. J Virol Methods. 2018 08; 258:41-48. PMID: 29763640.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    18. Shirato K, Kawase M, Matsuyama S. Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. Virology. 2018 04; 517:9-15. PMID: 29217279.
      Citations: 67     Fields:    Translation:HumansCells
    19. Shirato K, Kanou K, Kawase M, Matsuyama S. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry. J Virol. 2017 Jan 01; 91(1). PMID: 27733646.
      Citations: 54     Fields:    Translation:HumansCells
    20. Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. Antimicrob Agents Chemother. 2016 11; 60(11):6532-6539. PMID: 27550352.
      Citations: 145     Fields:    Translation:HumansCells
    21. Shirato K, Maejima M, Islam MT, Miyazaki A, Kawase M, Matsuyama S, Taguchi F. Porcine aminopeptidase N is not a cellular receptor of porcine epidemic diarrhea virus, but promotes its infectivity via aminopeptidase activity. J Gen Virol. 2016 10; 97(10):2528-2539. PMID: 27449937.
      Citations: 23     Fields:    Translation:AnimalsCells
    22. Yamaoka Y, Matsuyama S, Fukushi S, Matsunaga S, Matsushima Y, Kuroyama H, Kimura H, Takeda M, Chimuro T, Ryo A. Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen. Front Microbiol. 2016; 7:509. PMID: 27148198.
      Citations: 16     
    23. Shirato K, Azumano A, Nakao T, Hagihara D, Ishida M, Tamai K, Yamazaki K, Kawase M, Okamoto Y, Kawakami S, Okada N, Fukushima K, Nakajima K, Matsuyama S. Middle East respiratory syndrome coronavirus infection not found in camels in Japan. Jpn J Infect Dis. 2015; 68(3):256-8. PMID: 25993975.
      Citations: 7     Fields:    Translation:AnimalsCells
    24. Shirato K, Yano T, Senba S, Akachi S, Kobayashi T, Nishinaka T, Notomi T, Matsuyama S. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J. 2014 Aug 08; 11:139. PMID: 25103205.
      Citations: 58     Fields:    Translation:HumansAnimalsCells
    25. Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. J Med Virol. 2014 Dec; 86(12):2146-53. PMID: 24760654.
      Citations: 42     Fields:    Translation:HumansCells
    26. Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol. 2013 Dec; 87(23):12552-61. PMID: 24027332.
      Citations: 197     Fields:    Translation:HumansCells
    27. Shirato K, Kawase M, Watanabe O, Hirokawa C, Matsuyama S, Nishimura H, Taguchi F. Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein. J Gen Virol. 2012 Sep; 93(Pt 9):1908-1917. PMID: 22673931.
      Citations: 17     Fields:    Translation:HumansCells
    28. Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol. 2012 Jun; 86(12):6537-45. PMID: 22496216.
      Citations: 215     Fields:    Translation:HumansCells
    29. Ujike M, Huang C, Shirato K, Matsuyama S, Makino S, Taguchi F. Two palmitylated cysteine residues of the severe acute respiratory syndrome coronavirus spike (S) protein are critical for S incorporation into virus-like particles, but not for M-S co-localization. J Gen Virol. 2012 Apr; 93(Pt 4):823-828. PMID: 22238235.
      Citations: 8     Fields:    Translation:AnimalsCells
    30. Shirato K, Maeda K, Tsuda S, Suzuki K, Watanabe S, Shimoda H, Ueda N, Iha K, Taniguchi S, Kyuwa S, Endoh D, Matsuyama S, Kurane I, Saijo M, Morikawa S, Yoshikawa Y, Akashi H, Mizutani T. Detection of bat coronaviruses from Miniopterus fuliginosus in Japan. Virus Genes. 2012 Feb; 44(1):40-4. PMID: 21877208.
      Citations: 10     Fields:    Translation:AnimalsCells
    31. Shirato K, Maejima M, Matsuyama S, Ujike M, Miyazaki A, Takeyama N, Ikeda H, Taguchi F. Mutation in the cytoplasmic retrieval signal of porcine epidemic diarrhea virus spike (S) protein is responsible for enhanced fusion activity. Virus Res. 2011 Nov; 161(2):188-93. PMID: 21840351.
      Citations: 11     Fields:    Translation:AnimalsCells
    32. Matsuyama S. [Protease-dependent cell entry mechanism of coronaviruses]. Uirusu. 2011 Jun; 61(1):109-16. PMID: 21972562.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    33. Shirato K, Matsuyama S, Ujike M, Taguchi F. Role of proteases in the release of porcine epidemic diarrhea virus from infected cells. J Virol. 2011 Aug; 85(15):7872-80. PMID: 21613395.
      Citations: 43     Fields:    Translation:AnimalsCells
    34. Kashiwazaki H, Nomura R, Matsuyama S, Taguchi F, Watanabe R. Spongiform degeneration induced by neuropathogenic murine coronavirus infection. Pathol Int. 2011 Apr; 61(4):184-91. PMID: 21418390.
      Citations: 2     Fields:    Translation:Animals
    35. Nomura R, Kashiwazaki H, Kakizaki M, Matsuyama S, Taguchi F, Watanabe R. Receptor-independent infection by mutant viruses newly isolated from the neuropathogenic mouse hepatitis virus srr7 detected through a combination of spinoculation and ultraviolet radiation. Jpn J Infect Dis. 2011; 64(6):499-505. PMID: 22116329.
      Citations: 1     Fields:    Translation:AnimalsCells
    36. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010 Dec; 84(24):12658-64. PMID: 20926566.
      Citations: 329     Fields:    Translation:HumansAnimalsCells
    37. Kyuwa S, Takagaki S, Matsuyama S, Taguchi F, Saegusa J, Iwakura Y, Tagawa Y, Yoshikawa Y. Characterization of a variant virus from ascitic fluid of subacute granulomatous serositis in interferon-gamma-deficient C57BL/6 mice persistently infected with murine coronavirus strain JHM. Viral Immunol. 2010 Aug; 23(4):437-42. PMID: 20712488.
      Citations: 1     Fields:    Translation:AnimalsCells
    38. Taguchi F, Matsuyama S. [Cell entry mechanisms of coronaviruses]. Uirusu. 2009 Dec; 59(2):215-22. PMID: 20218330.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    39. Matsuyama S, Taguchi F. Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. J Virol. 2009 Nov; 83(21):11133-41. PMID: 19706706.
      Citations: 44     Fields:    Translation:AnimalsCells
    40. Kawase M, Shirato K, Matsuyama S, Taguchi F. Protease-mediated entry via the endosome of human coronavirus 229E. J Virol. 2009 Jan; 83(2):712-21. PMID: 18971274.
      Citations: 59     Fields:    Translation:HumansCells
    41. Watanabe R, Matsuyama S, Shirato K, Maejima M, Fukushi S, Morikawa S, Taguchi F. Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J Virol. 2008 Dec; 82(23):11985-91. PMID: 18786990.
      Citations: 46     Fields:    Translation:HumansCells
    42. Watanabe R, Matsuyama S, Taguchi F. Receptor-independent infection of murine coronavirus: analysis by spinoculation. J Virol. 2006 May; 80(10):4901-8. PMID: 16641281.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    43. Matsuyama S, Ujike M, Ishii K, Fukushi S, Morikawa S, Tashiro M, Taguchi F. Enhancement of SARS-CoV infection by proteases. Adv Exp Med Biol. 2006; 581:253-8. PMID: 17037538.
      Citations:    Fields:    Translation:AnimalsCells
    44. Fukushi S, Mizutani T, Saijo M, Matsuyama S, Taguchi F, Kurane I, Morikawa S. Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein. Adv Exp Med Biol. 2006; 581:293-6. PMID: 17037546.
      Citations: 2     Fields:    Translation:HumansCells
    45. Matsuyama S, Ujike M, Morikawa S, Tashiro M, Taguchi F. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12543-7. PMID: 16116101.
      Citations: 139     Fields:    Translation:AnimalsCells
    46. Fukushi S, Mizutani T, Saijo M, Matsuyama S, Miyajima N, Taguchi F, Itamura S, Kurane I, Morikawa S. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol. 2005 Aug; 86(Pt 8):2269-2274. PMID: 16033974.
      Citations: 72     Fields:    Translation:HumansAnimalsCells
    47. Saijo M, Ogino T, Taguchi F, Fukushi S, Mizutani T, Notomi T, Kanda H, Minekawa H, Matsuyama S, Long HT, Hanh NT, Kurane I, Tashiro M, Morikawa S. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J Virol Methods. 2005 May; 125(2):181-6. PMID: 15794988.
      Citations: 8     Fields:    Translation:AnimalsCells
    48. Matsuyama S, Taguchi F. Receptor-induced conformational changes of murine coronavirus spike protein. J Virol. 2002 Dec; 76(23):11819-26. PMID: 12414924.
      Citations: 47     Fields:    Translation:AnimalsCells
    49. Matsuyama S, Taguchi F. Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor. Virology. 2002 Mar 30; 295(1):160-71. PMID: 12033774.
      Citations: 14     Fields:    Translation:AnimalsCells
    50. Taguchi F, Matsuyama S. Soluble receptor potentiates receptor-independent infection by murine coronavirus. J Virol. 2002 Feb; 76(3):950-8. PMID: 11773370.
      Citations: 29     Fields:    Translation:AnimalsCells
    51. Matsuyama S, Watanabe R, Taguchi F. Neurovirulence for mice of soluble receptor-resistant mutants of murine coronavirus JHMV. Adv Exp Med Biol. 2001; 494:145-8. PMID: 11774459.
      Citations:    Fields:    Translation:AnimalsCells
    52. Matsuyama S, Taguchi F. Inefficient infection of soluble receptor-resistant mutants of murine coronavirus in cells expressing MHVR2 receptor. Adv Exp Med Biol. 2001; 494:233-6. PMID: 11774474.
      Citations:    Fields:    Translation:AnimalsCells
    53. Matsuyama S, Taguchi F. Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor. Virology. 2000 Jul 20; 273(1):80-9. PMID: 10891410.
      Citations: 10     Fields:    Translation:AnimalsCells
    Matsuyama's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (216)
    Explore
    _
    Co-Authors (90)
    Explore
    _
    Similar People (60)
    Explore
    _